Company Encyclopedia
View More
name
Jinhe Biotechnology
002688.SZ
Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China. It offers chlortetracycline feed grade, an antimicrobial drug for the inhibition and treatment of white dysentery, enteritis, pneumonia, typhoid, paratyphoid, cholera, etc. in poultry and livestock; and chlortetracycline hydrochloride for the inhibition and treatment of pullorum disease, typhoid, and swine enteritis, as well as bacterial diseases, including paratyphoid and cholera.
3.159 T
002688.SZMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
B
PharmaceuticalsIndustry
Industry Ranking56/223
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE5.47%C
    • Profit Margin4.56%C
    • Gross Margin32.19%C
  • Growth ScoreB
    • Revenue YoY21.58%A
    • Net Profit YoY29.19%B
    • Total Assets YoY-2.67%D
    • Net Assets YoY3.67%C
  • Cash ScoreA
    • Cash Flow Margin2190.75%A
    • OCF YoY21.58%A
  • Operating ScoreC
    • Turnover0.49C
  • Debt ScoreC
    • Gearing Ratio53.45%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Jinhe Biotechnology: Feed additive red yeast rice has obtained product approval number

    According to the Zhitong Finance APP, Jinhe Biotechnology announced that the company has received the "Approval Form for Feed Additive Product Approval Number" issued by the Inner Mongolia Autonomous Region Department of Agriculture and Animal Husbandry. The feed additive red yeast developed by the company has obtained the product approval number

    Zhitong·
    SZ
    002688
    +0.99%
    Zhitong·
    SZ
    002688
    +0.99%

    Jinhe Biotechnology: Plans to sell assets for RMB 21.1212 million

    Jinhe Biotechnology announced that it plans to sell the Jinhe Phase VI steam long-distance pipeline to Inner Mongolia Tokto Economic Development Zone Investment and Construction Co., Ltd. for RMB 21.1212 million. The total length of the target asset is 5,257.78 meters, which is the steam long-distance pipeline built by the company during the production process of Phase VI project. The counterparty is a wholly-owned subsidiary of the Tokto County Finance Bureau, and this transaction will not affect the company's normal production and operation activities

    Zhitong·
    SZ
    002688
    +0.99%
    Zhitong·
    SZ
    002688
    +0.99%

    Jinhe Biotechnology plans to raise no more than 300 million yuan through a simplified procedure for private placement

    Jinhe Biotechnology plans to issue A-shares to specific targets through a simplified procedure, raising no more than 300 million yuan. This issuance will be aimed at no more than 35 specific targets, with the issuance price not lower than 80% of the average price of the 20 trading days prior to the pricing benchmark date. The raised funds will be used for the expansion of sewage treatment capacity, upgrading and expanding water resource recycling, constructing new grain storage facilities, and supplementing working capital

    Zhitong·
    SZ
    002688
    +0.99%
    Zhitong·
    SZ
    002688
    +0.99%

    Jinhe Biotechnology plans to raise funds via private placement

    Jinhe Biotechnology plans to raise funds via private placement

    marketscreener·
    SZ
    002688
    +0.99%
    marketscreener·
    SZ
    002688
    +0.99%

    Jinhe Biotechnology: Discloses a simplified procedure for issuing stocks in 2025

    Jinhe Biotechnology announced that the company held a board of directors and supervisory board meeting on October 13, 2025, and approved the proposal to issue stocks to specific targets through a simplified procedure. The proposal and related documents were disclosed on October 15, 2025, on the Giant Tide Information Network. The relevant matters of this stock issuance are still subject to approval or registration by the relevant regulatory authorities, and investors are advised to pay attention to investment risks

    Zhitong·
    SZ
    002688
    +0.99%
    Zhitong·
    SZ
    002688
    +0.99%
    © 2025 Longbridge｜Disclaimer